Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Animal Models

Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet

Abstract

Background/Objectives:

Obesity is characterized by chronic inflammation and immune dysregulation, as well as insulin resistance, but the link between obesity and adaptive immunity remains to be fully studied.

Methods:

To elucidate the role of adaptive immunity on body composition, glucose homeostasis and inflammation, recombination-activating gene 1 knockout (Rag1−/−) mice, without mature T-lymphocytes or B-lymphocytes, were maintained on a low- or high-fat diet (LFD and HFD, respectively) for 11 weeks.

Results:

Rag1−/− mice fed HFD gained significantly more weight and had increased body fat compared with wild type. Downregulation of energy expenditure as well as brown fat uncoupling protein UCP-1 and UCP-3 gene expression were noticed in HFD-fed Rag1−/− mice compared with LFD. HFD mice had significantly decreased energy intake compared with LFD mice, consistent with decreased agouti-related protein and increased pro-opiomelanocortin gene expression levels in the hypothalamus. Moreover, compared with wild type, Rag1−/− mice had lower interleukin (IL)-4 levels, a cytokine recently found to induce browning in white adipocytes, and higher IL-12 levels in HFD-fed Rag1−/− mice. Despite that HFD Rag1−/− mice were more obese, they had similar glucose, insulin and adiponectin levels, while leptin was marginally increased.

Conclusions:

Mice with deficiency in adaptive immunity are obese, partly owing to decreased energy expenditure, but are metabolically normal, suggesting that mature lymphocytes have necessary roles in the development of obesity-related metabolic dysregulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689.

    Article  CAS  PubMed  Google Scholar 

  2. Lumeng CN, Saltiel AR . Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111–2117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Michaud A, Boulet MM, Veilleux A, Noel S, Paris G, Tchernof A . Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism 2014; 63: 372–381.

    Article  CAS  PubMed  Google Scholar 

  4. van Beek L, Lips MA, Visser A, Pijl H, Ioan-Facsinay A, Toes R et al. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism 2014; 63: 492–501.

    Article  CAS  PubMed  Google Scholar 

  5. Lee BC, Lee J . Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta 2014; 1842: 446–462.

    Article  CAS  PubMed  Google Scholar 

  6. Odegaard JI, Chawla A . Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013; 339: 172–177.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Olefsky JM, Glass CK . Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72: 219–246.

    Article  CAS  PubMed  Google Scholar 

  8. Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR . Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 2013; 62: 1543–1552.

    Article  CAS  PubMed  Google Scholar 

  9. Nieman DC, Henson DA, Nehlsen-Cannarella SL, Ekkens M, Utter AC, Butterworth DE et al. Influence of obesity on immune function. J Am Diet Assoc 1999; 99: 294–299.

    Article  CAS  PubMed  Google Scholar 

  10. Krinninger P, Ensenauer R, Ehlers K, Rauh K, Stoll J, Krauss-Etschmann S et al. Peripheral monocytes of obese women display increased chemokine receptor expression and migration capacity. J Clin Endocrinol Metab 2014; 99: 2500–2509.

    Article  CAS  PubMed  Google Scholar 

  11. Mraz M, Haluzik M . The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222: R113–R127.

    Article  CAS  PubMed  Google Scholar 

  12. Cildir G, Akincilar SC, Tergaonkar V . Chronic adipose tissue inflammation: all immune cells on the stage. Trends Mol Med 2013; 19: 487–500.

    Article  CAS  PubMed  Google Scholar 

  13. Patel PS, Buras ED, Balasubramanyam A . The role of the immune system in obesity and insulin resistance. J Obes 2013; 2013: 616193.

    PubMed  PubMed Central  Google Scholar 

  14. Lumeng CN, Bodzin JL, Saltiel AR . Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117: 175–184.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE . RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869–877.

    Article  CAS  PubMed  Google Scholar 

  16. Bluher S, Moschos S, Bullen J Jr, Kokkotou E, Maratos-Flier E, Wiegand SJ et al. Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 2004; 53: 2787–2796.

    Article  PubMed  Google Scholar 

  17. Lee DH, Huang H, Choi K, Mantzoros C, Kim YB . Selective PPARgamma modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice. Am J Physiol Endocrinol Metab 2012; 302: E552–E560.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hausberg M, Morgan DA, Mitchell JL, Sivitz WI, Mark AL, Haynes WG . Leptin potentiates thermogenic sympathetic responses to hypothermia: a receptor-mediated effect. Diabetes 2002; 51: 2434–2440.

    Article  CAS  PubMed  Google Scholar 

  19. Nguyen AD, Herzog H, Sainsbury A . Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr Opin Endocrinol Diabetes Obes 2011; 18: 56–60.

    Article  CAS  PubMed  Google Scholar 

  20. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921–929.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Duffaut C, Galitzky J, Lafontan M, Bouloumie A . Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009; 384: 482–485.

    Article  CAS  PubMed  Google Scholar 

  22. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996; 26: 659–668.

    Article  CAS  PubMed  Google Scholar 

  23. Suarez-Alvarez K, Solis-Lozano L, Leon-Cabrera S, Gonzalez-Chavez A, Gomez-Hernandez G, Quinones-Alvarez MS et al. Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters. Mediators Inflamm 2013; 2013: 967067.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H et al. Adaptive immune cells temper initial innate responses. Nat Med 2007; 13: 1248–1252.

    Article  CAS  PubMed  Google Scholar 

  25. Morris SC, Lees A, Finkelman FD . In vivo activation of naive T cells by antigen-presenting B cells. J Immunol 1994; 152: 3777–3785.

    CAS  PubMed  Google Scholar 

  26. Brown MA . IL-4 production by T cells: you need a little to get a lot. J Immunol 2008; 181: 2941–2942.

    Article  CAS  PubMed  Google Scholar 

  27. Chang YH, Ho KT, Lu SH, Huang CN, Shiau MY . Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4. Int J Obes (Lond) 2012; 36: 993–998.

    Article  CAS  Google Scholar 

  28. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, Jouihan H, Morel CR, Heredia JE et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci USA 2010; 107: 22617–22622.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157: 1292–1308.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014; 157: 1279–1291.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Primeau V, Coderre L, Karelis AD, Brochu M, Lavoie ME, Messier V et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971–981.

    Article  CAS  Google Scholar 

  32. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011; 34: 210–215.

    Article  PubMed  Google Scholar 

  33. Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A . Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 2013; 36: 2294–2300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Kramer CK, Zinman B, Retnakaran R . Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was conducted with support from Harvard Catalyst/The Harvard Clinical and Translational Science Center (NIH Award no. UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health-care centers), a discretionary grant from Beth Israel Deaconess Medical Center and award number 1I01CX000422-01A1 from the Clinical Science Research and Development Service of the VA Office of Research and Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health-care centers, the National Center for Research Resources or the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C S Mantzoros.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, X., Huh, J., Gong, H. et al. Lack of mature lymphocytes results in obese but metabolically healthy mice when fed a high-fat diet. Int J Obes 39, 1548–1557 (2015). https://doi.org/10.1038/ijo.2015.93

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2015.93

This article is cited by

Search

Quick links